Artemisinin Drug Resistance Threatens Mekong Region’s Progress Against Malaria

Financial Times: Malaria: Real and present danger
“…A potential comeback by malaria in Myanmar, Cambodia, and neighboring Mekong subregion countries risks quietly undoing years of progress in fighting this historical scourge in the world’s warmer regions. Health workers are finding growing numbers of sufferers of the disease for whom therapies based on artemisinin, a compound extracted from a grass used in Chinese traditional medicine, are no longer working properly…” (Peel/Ward, 12/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.